GLJ Research Reiterates Buy on Cleveland-Cliffs, Maintains $15.6 Price Target
GLJ Research analyst Gordon L. Johnson reiterates Cleveland-Cliffs (NYSE:CLF) with a Buy and maintains $15.6 price target.
Stocks · News reference
JP Morgan Maintains Neutral on Cleveland-Cliffs, Raises Price Target to $13
JP Morgan analyst Bennett Moore maintains Cleveland-Cliffs (NYSE:CLF) with a Neutral and raises the price target from $11 to $13.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Shares of copper-linked companies are trading higher on rising Chinese demand, after the Yangshan copper premium reached its highest level since October 2022. Supply issues and U.S. tariff concerns have contributed to recent strength.
Charles Schwab, UnitedHealth And Cleveland-Cliffs: CNBC’s ‘Final Trades’
CNBC final trades: Pros picked Schwab, Cleveland-Cliffs, UnitedHealth and Incyte; shares posted mixed moves Wednesday.
CNBC Halftime Report Final Trades: Charles Schwab, Cleveland-Cliffs, UnitedHealth Group, Incyte